Please assess the completion status of the following clinical trial:

Trial Title: Dynamic Substrate Mapping (DSM) for Ischemic VT

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Have an ICD or CRT-D device~* Had at least 3 documented device therapies to treat VT over last 3 months~* Clinical VT is confirmed or suspected to be of ischemic origin~* Scheduled for VT ablation procedure~* LVEF \> or = 20%~Exclusion Criteria:~* Inadequate AAD washout (amiodarone should be maintained at current dose)~* Unstable angina~* Active ischemia~* Cardiac surgery within prior 2 months~* Evidence of infection~* Prosthetic mitral or aortic valve or mitral/aortic valvular heart disease requiring surgical intervention~* History of embolic event~* Myocardial infarction within prior 6 weeks~* Enrolled in another study~* Recurrent sepsis or otherwise not a candidate for catheterization~* Hypercoagulable state or inability to tolerate heparin therapy during procedure~* Has had an atriotomy or ventriculotomy within prior 4 months~* Life expectancy \< 6 months~* Class IV NYHA classification

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- DSM (Type: ACTIVE_COMPARATOR): Treatment using DSM to guide ablation

Based on this trial design, predict the completion outcome and termination type (if applicable).